phase readout
saveNCT07493980: Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients
NOT_YET_RECRUITINGupdated 51m ago
community read0 votes
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: PHASE2. Conditions: NSCLC Stage II
view source ↗
comments(0)
5-min edit window · permanent after that